在过去的20年里,肝脏再移植的风险是否有所改善?
Miho Akabane1, Yuki Bekki2, Yuki Imaoka1
1Division of Abdominal Transplant, Department of Surgery, Stanford University Medical Center, Stanford, California, USA.
Clinical transplantation
|September 29, 2023
概括
肝脏再移植 (re-LT) 的结果有所改善,但移植存活率仍然低于标准肝脏移植. 需要进一步的研究来优化风险分层和分配,以获得更好的再LT结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植医学 移植医学
- 器官捐赠和移植器官的使用
背景情况:
- 肝移植 (LT) 已经进步,但肝脏再移植 (re-LT) 仍然存在重大临床挑战.
- 了解re-LT的趋势和结果对于改善患者存活率和移植长寿至关重要.
研究的目的:
- 评估过去二十年来肝脏再移植 (re-LT) 结果的改善情况.
- 确定有助于重新LT的成功或失败的关键因素.
主要方法:
- 来自美国器官共享网络数据库 (2002-2021) 的数据分析.
- 接受者被分为四年间隔,以评估重新LT特征和术后结果的趋势.
- 与边际捐赠者进行再LT结局的比较,包括循环死亡 (DCD) 后的捐赠者.
主要成果:
- 从2018年到2021年,重新LT的移植存活率有所改善,但与DCD捐赠者相比,移植存活率的危险比率仍然很高.
- 重复LT的原因发生了转变,降低了型肝炎复发率和增加了涉及DCD的初级LT后的移植失败.
- 在紧急重新LT中观察到更短的冷缺血时间 (CIT),而DCD队列显示了CIT更明显的下降.
结论:
- 尽管短期有所改善,但重新LT的结果仍然面临挑战,特别是与DCD捐赠者相比.
- 目前正在进行的研究应侧重于完善风险分层模型和器官分配系统,以提高肝脏再移植的成功率.
相关概念视频
Kidney Transplant I: Introduction
14
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
14
Kidney Transplant II: Surgical Procedure
22
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
22
Tissue Transplantation
391
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
391
Bone Marrow Sampling and Transplants
352
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
352


